Now showing items 1-8 of 8

    • Safe, Stephen S. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-04-03)
      The present embodiment of the invention is generally directed to compositions comprising suspensions of poorly water soluble compounds recrystallized in nanoparticulate sizes ranging from 0.1 to 5 ?m. In addition, the ...
    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-03-05)
      The present embodiment of the invention is generally directed to compositions comprising suspensions of poorly water soluble compounds recrystallized in nanoparticulate sizes ranging from 0.1 to 5 ?m. In addition, the ...
    • Safe, Stephen S. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2007-06-19)
      Disclosed are methods and compositions for the treatment of a wide array of cancers and tumors. In illustrative embodiments, diindolylmethanes, C-substituted diindolylmethanes, and analogs thereof have been described, which ...
    • Zingaro, Ralph A.; Duzkale, Hatice; Freireich, Emil J.; Kantarjian, Hagop; Sotelo-lerma, Merida; Verstovsek, Srdan; Gao, Mingzhang (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2008-07-29)
      The present invention provides organic arsenicals. Many of these compounds have potent in vitro cytotoxic activity against numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant ...
    • Safe, Stephen H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-05-04)
      Disclosed are methods and compositions for the treatment of a wide array of cancers and tumors. In illustrative embodiments, diindolylmethanes, C-substituted diindolylmethanes, and analogs thereof have been described, which ...
    • Xu, Xuejun; Hook, Magnus; Kim, Jiyeun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-04-07)
      The present invention identified a high affinity binding sequence in collagen type III for the collagen-binding integrin I domains. Provided herein are the methods used to characterize the sequence, the peptides comprising ...
    • Hook, Magnus; Xu, Xuejun; Kim, Jiyeun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-07-23)
      The present invention identified a high affinity binding sequence in collagen type III for the collagen-binding integrin I domains. Provided herein are the methods used to characterize the sequence, the peptides comprising ...
    • Hook, Magnus; Xu, Xuejun; Kim, Jiyeun (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-08-28)
      The present invention identified a high affinity binding sequence in collagen type III for the collagen-binding integrin I domains. Provided herein are the methods used to characterize the sequence, the peptides comprising ...